Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation
Dirk H. Walter, MDa,
Stephan Fichtlscherer, MDa,
Marc Sellwig, BSa,
Wolfgang Auch-Schwelk, MDa,
Volker Schächinger, MDa and
Andreas M. Zeiher, MDa
a Department of Internal Medicine IV, Division of Cardiology, University of Frankfurt, Frankfurt, Germany

View larger version (20K):
[in a new window]
|
Figure 1 Cumulative frequency distribution curves of the MLD for tertiles of CRP levels pre-, post-stent implantation and at six-month follow-up angiography. For graphical reasons, the two upper tertiles ( 0.5 mg/dl) were combined (dotted line with circles) and compared with the lowest tertile (<0.5 mg/dl). CRP = C-reactive protein; MLD = minimal lumen diameter.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Long-term clinical adverse events (death due to cardiac causes, myocardial infarction of the target vessel and target vessel revascularization) within tertiles of CRP levels are compared by Kaplan-Meier survival curves, and the corresponding p value was obtained from the log-rank test. CRP = C-reactive protein.
|
|
|